Local Institution - 0075

Barcelona 8035

1 studies enrolling now · 2 studies all time

What they study most

Non-Small Cell Lung Cancer, Pulmonary Fibrosis

Studies at this site

• Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis — Starting soon
• A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer — Completed